Kanta Subbarao

43.6k total citations · 12 hit papers
305 papers, 27.4k citations indexed

About

Kanta Subbarao is a scholar working on Epidemiology, Infectious Diseases and Agronomy and Crop Science. According to data from OpenAlex, Kanta Subbarao has authored 305 papers receiving a total of 27.4k indexed citations (citations by other indexed papers that have themselves been cited), including 226 papers in Epidemiology, 159 papers in Infectious Diseases and 65 papers in Agronomy and Crop Science. Recurrent topics in Kanta Subbarao's work include Influenza Virus Research Studies (209 papers), Respiratory viral infections research (148 papers) and SARS-CoV-2 and COVID-19 Research (88 papers). Kanta Subbarao is often cited by papers focused on Influenza Virus Research Studies (209 papers), Respiratory viral infections research (148 papers) and SARS-CoV-2 and COVID-19 Research (88 papers). Kanta Subbarao collaborates with scholars based in United States, Australia and United Kingdom. Kanta Subbarao's co-authors include Brian R. Murphy, Nancy J. Cox, Anjeanette Roberts, Leatrice Vogel, Elaine W. Lamirande, Catharine I. Paules, Xiyan Xu, William T. London, Catherine J. Luke and Stephen J. Kent and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Kanta Subbarao

301 papers receiving 26.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

2021 2.1k citations David S. Khoury, Deborah Cromer et al. profile →
Characterization of an Avian Influenza A (H5N1) Virus Isolated from a Child with a Fatal Respiratory Illness

1998 1.1k citations Kanta Subbarao, Thomas Rowe et al. profile →
A single amino acid in the PB2 gene of influenza A virus is a determinant of host range

1993 749 citations Kanta Subbarao et al. Journal of Virology profile →
Genetic Characterization of the Pathogenic Influenza A/Goose/Guangdong/1/96 (H5N1) Virus: Similarity of Its Hemagglutinin Gene to Those of H5N1 Viruses from the 1997 Outbreaks in Hong Kong

1999 625 citations Xiyan Xu, Kanta Subbarao et al. profile →
Global Epidemiology of Influenza: Past and Present

2000 625 citations Kanta Subbarao et al. profile →
Systems biology of vaccination for seasonal influenza in humans

2011 587 citations Kanta Subbarao et al. profile →
An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus

2004 541 citations Kanta Subbarao et al. profile →
Influenza

2017 541 citations Kanta Subbarao et al. profile →
Avian-to-human transmission of H9N2 subtype influenza A viruses: Relationship between H9N2 and H5N1 human isolates

2000 520 citations Kanta Subbarao et al. Proceedings of the National Academy of Sciences profile →
A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

2004 509 citations Anjeanette Roberts, Kanta Subbarao et al. profile →
Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV

2004 503 citations Kanta Subbarao et al. profile →
Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 Infection

2023 72 citations David S. Khoury, Deborah Cromer et al. profile →

Peers

Countries citing papers authored by Kanta Subbarao

Since Specialization

Citations

This map shows the geographic impact of Kanta Subbarao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kanta Subbarao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kanta Subbarao more than expected).

Fields of papers citing papers by Kanta Subbarao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kanta Subbarao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kanta Subbarao. The network helps show where Kanta Subbarao may publish in the future.

Co-authorship network of co-authors of Kanta Subbarao

This figure shows the co-authorship network connecting the top 25 collaborators of Kanta Subbarao. A scholar is included among the top collaborators of Kanta Subbarao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kanta Subbarao. Kanta Subbarao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Contemporary seasonal human coronaviruses display differences in cellular tropism compared to laboratory-adapted reference strains 2025 ·Journal of Virology ·Matthew J. Gartner, Monique L. Smith, Clyde Dapat, Y‐F Liaw, Thomas Tran, (unknown), Joseph Chen, Guizhi Sun, (unknown), George Taiaroa, Michael J. Roche, Wen Shi Lee, Philip Robinson, José M. Polo, Kanta Subbarao, Jessica A. Neil	1
2	Inno4Vac Workshop Report Part 1: Controlled Human Influenza Virus Infection Model (CHIVIM) Strain Selection and Immune Assays for CHIVIM Studies, November 2021, MHRA, UK 2024 ·Influenza and Other Respiratory Viruses ·Joanna Waldock, Rebecca Jane Cox, (unknown), Kanta Subbarao, Adrian Wildfire, William Barclay, Puck B. van Kasteren, John W. McCauley, Colin A. Russell, Derek J. Smith, Ryan S. Thwaites, John S. Tregoning, (unknown)	0
3	Implications of the apparent extinction of B/Yamagata-lineage human influenza viruses 2024 ·npj Vaccines ·Ian Barr, Kanta Subbarao	5
4	A placental model of SARS-CoV-2 infection reveals ACE2-dependent susceptibility and differentiation impairment in syncytiotrophoblasts 2023 ·Nature Cell Biology ·Joseph Chen, Jessica A. Neil, Jianping Tan, Rajeev Rudraraju, Monika Mohenska, Yu Sun, E. Haydn Walters, Naiara G. Bediaga, Guohui Sun, Yisu Zhou, Yingchun Li, Damien R. Drew, Phillip Pymm, Wai‐Hong Tham, (unknown), Fernando J. Rossello, Guiying Nie, Xiaodong Liu, Kanta Subbarao, José M. Polo	20
5	Antibody titres elicited by the 2018 seasonal inactivated influenza vaccine decline by 3 months post‐vaccination but persist for at least 6 months 2022 ·Influenza and Other Respiratory Viruses ·Francesca L. Mordant, Olivia Price, Rajeev Rudraraju, Monica A. Slavin, Caroline Marshall, Leon J. Worth, Heidi Peck, Ian Barr, Sheena G. Sullivan, Kanta Subbarao	11
6	Sequential Transmission of Influenza Viruses in Ferrets Does Not Enhance Infectivity and Does Not Predict Transmissibility in Humans 2022 ·mBio ·Troy C. Sutton, Elaine W. Lamirande, (unknown), (unknown), Rita Czakó, Elodie Ghedin, Raphael Tze Chuen Lee, Sebastian Maurer‐Stroh, Kanta Subbarao	9
7	Heparin Inhibits SARS-CoV-2 Replication in Human Nasal Epithelial Cells 2022 ·Viruses ·Leo Lee, (unknown), (unknown), Vera Ignjatović, Damian F. J. Purcell, Philip Robinson, Craig J. Morton, Michael W. Parker, Gary P. Anderson, Paul Monagle, Kanta Subbarao, Jessica A. Neil	8
8	Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance 2021 ·Open Forum Infectious Diseases ·Suellen Nicholson, Theo Karapanagiotidis, Arseniy Khvorov, (unknown), Francesca L. Mordant, Katherine Bond, Julian Druce, Deborah A. Williamson, Damian F. J. Purcell, Sharon R. Lewin, Sheena G. Sullivan, Kanta Subbarao, Mike Catton	15
9	Transcriptional and epi-transcriptional dynamics of SARS-CoV-2 during cellular infection 2021 ·Cell Reports ·Jessie J.‐Y. Chang, (unknown), Miranda E. Pitt, George Taiaroa, (unknown), Chenxi Zhou, Francesca L. Mordant, Ricardo De Paoli‐Iseppi, Leon Caly, Damian F. J. Purcell, Timothy P. Stinear, Sarah L. Londrigan, Michael B. Clark, Deborah A. Williamson, Kanta Subbarao, Lachlan Coin	24
10	Evaluation of Serological Tests for SARS-CoV-2: Implications for Serology Testing in a Low-Prevalence Setting 2020 ·The Journal of Infectious Diseases ·Katherine Bond, Suellen Nicholson, Seok Lim, Theo Karapanagiotidis, Eloise Williams, Douglas Johnson, Tuyet Hoang, (unknown), Damian F. J. Purcell, Francesca L. Mordant, Sharon R. Lewin, Mike Catton, Kanta Subbarao, Benjamin P. Howden, Deborah A. Williamson	38
11	Integrating genotypes and phenotypes improves long-term forecasts of seasonal influenza A/H3N2 evolution 2020 ·eLife ·John Huddleston, John Barnes, Thomas Rowe, Xiyan Xu, Rebecca Kondor, David E. Wentworth, Lynne Whittaker, Burcu Ermetal, Rodney S. Daniels, John W. McCauley, Seiichiro Fujisaki, Kazuya Nakamura, Noriko Kishida, Shinji Watanabe, Hideki Hasegawa, Ian Barr, Kanta Subbarao, Pierre Barrat-Charlaix, Richard A. Neher, Trevor Bedford	40
12	Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models 2020 ·Nature reviews. Immunology ·David S. Khoury, Adam K. Wheatley, Mitchell D. Ramuta, Arnold Reynaldi, Deborah Cromer, Kanta Subbarao, David H. O’Connor, Stephen J. Kent, Miles P. Davenport	81
13	Consensus summary report for CEPI/BC March 12–13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines 2020 ·Vaccine ·Paul‐Henri Lambert, Donna M. Ambrosino, Svein Rune Andersen, Ralph S. Baric, Steven Black, Robert T. Chen, Cornelia L. Dekker, Arnaud M. Didierlaurent, Barney S. Graham, (unknown), Deborah C. Molrine, Stanley Perlman, (unknown), Andrew J. Pollard, Chuan Qin, Kanta Subbarao, Jakob P. Cramer	73
14	Immune Responses to Avian Influenza Viruses 2019 ·The Journal of Immunology ·Marios Koutsakos, Katherine Kedzierska, Kanta Subbarao	51
15	Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model 2018 ·Infection Genetics and Evolution ·Daniil Korenkov, Karen Laurie, Patrick C. Reading, Louise Carolan, Kok Fei Chan, (unknown), (unknown), Kanta Subbarao, Ian Barr, Julie Villanueva, (unknown), Tatiana Bousse, Larisa Rudenko	12
16	In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination 2017 ·PLoS neglected tropical diseases ·Stephen S. Whitehead, Anna P. Durbin, Kristen K. Pierce, (unknown), Benjamin D. McElvany, (unknown), Marya P. Carmolli, Cecilia Tibery, Noreen A. Hynes, (unknown), (unknown), Catherine J. Larsson, (unknown), Dorothy M. Dickson, Catherine J. Luke, Kanta Subbarao, Sean A. Diehl, Beth D. Kirkpatrick	80
17	Heterovariant Cross-Reactive B-Cell Responses Induced by the 2009 Pandemic Influenza Virus A Subtype H1N1 Vaccine 2012 ·The Journal of Infectious Diseases ·Xiaosong He, Sanae Sasaki, (unknown), Surender Khurana, Hana Golding, John J. Treanor, David J. Topham, Mark Y. Sangster, Hong Jin, Cornelia L. Dekker, Kanta Subbarao, Harry B. Greenberg	17
18	Seasonal influenza infection and live vaccine prime for a response to the 2009 pandemic H1N1 vaccine 2011 ·Proceedings of the National Academy of Sciences ·Grace Chen, (unknown), Elaine W. Lamirande, Amber W. McCall, Kanta Subbarao	49
19	A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice 2007 ·PLoS Pathogens ·Anjeanette Roberts, Damon Deming, Christopher D. Paddock, Aaron Cheng, Boyd L. Yount, Leatrice Vogel, Brian D. Herman, Tim Sheahan, Mark T. Heise, Gillian L. Genrich, Sherif R. Zaki, Ralph S. Baric, Kanta Subbarao	335
20	Influenza Vaccines: Present and Future 1999 ·Advances in virus research ·Kanta Subbarao	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact